← Back to Search

Other

1 for Obstructive Sleep Apnea

Phase 2

Waitlist Available

Led By Eric J Kezirian, MD, MPH

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up preoperative and postoperative

Awards & highlights

Study Summary

This trial is studying a new way to examine the upper airway in people with obstructive sleep apnea who are getting surgery for their sleep apnea. The study is finding out how well this new technique works and if it can help predict who will or will not respond to sleep apnea surgery.

Eligible Conditions

Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ preoperative and postoperative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~preoperative and postoperative

This trial's timeline: 3 weeks for screening, Varies for treatment, and preoperative and postoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Association between DISE and physical examination; between DISE and polysomnogram results; between DISE and awake Mueller maneuver; between DISE and lateral cephalometry; and between DISE findings and surgical outcomes

Trial Design

1Treatment groups

Experimental Treatment

Group I: 1Experimental Treatment1 Intervention

OSA Patients considering surgical treatment

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,528 Previous Clinical Trials

10,275,651 Total Patients Enrolled

American Academy of Otolaryngology-Head and Neck Surgery FoundationOTHER

9 Previous Clinical Trials

596 Total Patients Enrolled

University of Southern CaliforniaLead Sponsor

905 Previous Clinical Trials

1,595,518 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the indications for this therapy?

"This medication is commonly used to help patients sedate during medical procedures, but it can also be part of monitored anesthesia care therapy and other types of sedative therapies."

Answered by AI

How many research subjects are a part of this clinical trial?

"The information available on clinicaltrials.gov suggests that this particular trial is still recruiting patients. The original posting date was February 1st, 2004 with the most recent edit being made on May 5th, 2022. This study will have 800 participants at 2 different locations."

Answered by AI

Has this particular therapy been cleared by the FDA?

"This treatment's safety was scored a 2 because, although there is some data supporting safety, there is no evidence that the medication is effective."

Answered by AI

Is this treatment backed by other medical research?

"Eighty ongoing clinical trials are looking into this proposed treatment with the majority of research being conducted in Jinan, Shandong. A total of 262 sites across the world are involved in these studies."

Answered by AI